drugset / Trial / NCT00142298
Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies
NaSingle-groupOpen-labelTreatment
Summary
This trial is being conducted as an open-label, extended-term study for patients with chronic hepatitis B who have previously completed an Idenix-sponsored trial with telbivudine.
Timeline
- Start
- 2005-03
- Primary completion
- 2009-11
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Telbivudine | Small molecule | 600 mg | Oral |